Navigation Links
New 'OPAL Therapy' presents simple, cost-effective method of treating HIV infection
Date:5/2/2008

Australian researchers have unveiled a new immunotherapy technique to help prevent the progression from HIV infection to AIDS. Details of the simple, cost-effective technique are published May 2nd in the open-access journal PLoS Pathogens.

There is an overwhelming need for effective immunotherapies for HIV, as current therapies are expensive, impractical, and often highly toxic. The authors, led by Professor Stephen Kent, propose a technique named OPAL therapyOverlapping Peptide-pulsed Autologous CeLlsa reinfusion of fresh blood cells incubating with overlapping SIV peptides. The OPAL technique was successfully tested in animal trials for stimulation of immunity, control of virus levels, and prevention of AIDS.

Vaccination diminished the levels of virus 10-fold lower than in controls, and was shown to be durable for over one year past initial vaccination. Therefore, viral replication was shown to be prolonged and more manageable, resulting in fewer deaths from AIDS.


'/>"/>

Contact: Mary Kohut
Press@plos.org
415-568-3457
Public Library of Science
Source:Eurekalert

Page: 1

Related medicine news :

1. Promising early evidence of the superior benefits of drug therapy for diabetic eye disease
2. American Humane Forms Human-Animal Bond Division, Including Animal-Assisted Therapy, Humane Ed and Pets & Womens Shelters
3. Immune-Boosting Lung Cancer Therapy Shows Promise
4. Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability
5. New Anal Cancer Therapy Fails to Improve Outcomes
6. Potential viral therapy weapon for difficult cancers is safe and effective in study
7. Chemotherapy causes delayed severe neural damage
8. Common Chemotherapy Drug Linked to Memory Problems
9. Study Shows Increased Out-of-Pocket Expenses May Negatively Influence Initiation of TNF Blocker Therapy
10. Get a Grip on Hand Therapy Prevention
11. Gene Therapy in Rats Reduces Cocaine Use

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...er 30 Simbionix USA Corporation,t... systems, in collaboration,with GORE Medical Produ...TM),workshop for the first time at the upcoming IC...imbionix PROcedure Rehearsal Studio(TM) is the wor...to create practice scenarios based on their,patien...
(Date:11/30/2009)...ealed that beverage can pull-tabs were being swall...acturers to stay-tabs. But a study presented today... of North America (RSNA) found that the new tabs a...ng factors leading the change in beverage can cons...swallowing of the pull-tab and potential related i...
(Date:11/30/2009)...n Medical Center researchers have found that infor...ns associated with asthma. The findings, available... suggest that interventions by parent mentors car...ecialized topical training can effectively reduce...nd missed adult workdays. , "Childhood asthma di...
(Date:11/29/2009).../ -- The following is an investment opinion releas...,, Intellivest Securities Research, Inc., ("ISR...blished a Report on BioClinica, Inc. ( BIOC) which...logy and medical device industries. A primary ser...submit medical imaging portions of their submissio...
(Date:11/29/2009)... to form between brain cells almost immediately as...blished this week in Nature . Led by researchers ...tudy involved detailed observations of the rewirin...tor learning. , The researchers studied mice as ... seed. They observed rapid growth of structures th...
Breaking Medicine News(10 mins):Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Beverage can stay-tabs pose swallowing risk 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3
...s and fresh food among barriers preventing Indiana...ts to take control of their diabetes , , INDIAN...COYD), a not-for-profit organization dedicated to ...ucted by national research firm Yankelovich which ...
...p, Inc. (OTC Bulletin Board: ANPG), reported today...Inc. (ESI) has increased its presence in the Korea...rom Korea for its EnviroTru(R) Disinfectant Cleane...business. , , About Anpath Group, Incorporated:...
...e Risk of Injury and Improve Your Vision and Your ...usiasts -- athletes and spectators alike -- are be... athletic fields, tracks and golf courses -- placi...il, each year there are more than 38,000 sports-re...
...ant size of the world,s smallest and thinnest high...n Scientific Corporation (NYSE: BSX ) today anno...Company,s ENDOTAK RELIANCE(R) 4-SITE defibrillatio...rapy defibrillator (CRT-D) to the heart and, when ...
...t didn,t break the skin , , TUESDAY, May 1...ther it pierced the skin or not, eased chronic low...were superior to usual care," said Daniel Cherkin,... pain. People receiving acupuncture are more likel...
...hield of Georgia (BCBSGA) announced today that it ...lent" for its HMO products from the National Commi...pendent, non-profit organization that evaluates ho...tinuously improve the quality of care and services...
Other Medicine News:Health News:Indianapolis Residents View Economic Challenges as Significant Barrier to Properly Managing Type 2 Diabetes 2Health News:Indianapolis Residents View Economic Challenges as Significant Barrier to Properly Managing Type 2 Diabetes 3Health News:Indianapolis Residents View Economic Challenges as Significant Barrier to Properly Managing Type 2 Diabetes 4Health News:Anpath Group, Inc. Increases Market Share in Korea 2Health News:Think Eye Protection This Season and All Year-Round 2Health News:Think Eye Protection This Season and All Year-Round 3Health News:Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process 2Health News:Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process 3Health News:Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process 4Health News:Acupuncture, Real or Fake, Eases Back Pain 2Health News:Acupuncture, Real or Fake, Eases Back Pain 3Health News:NCQA Accreditation Status of Excellence Awarded to Blue Cross and Blue Shield of Georgia 2
(Date:11/29/2009)...v. 29 FUJIFILM Medical Systems USA...volutionary flat panel DR cassette, at the 2009 Ra...Meeting. Ideal for any clinical environment, FDR ... clinicians with Fujifilm,s trademark image qualit...smart way for users to transition to DR without mo...
(Date:11/29/2009)...v. 29 Stimulated by the ten years ...lm Medical Systems USA announced today, at the Rad...eeting, the formation of its Medical Informatics ...is new group will integrate all functions associat...ates a platform for future growth. ,, Several o...
(Date:11/29/2009)...v. 29 Researchers using functional...activation have found that men and women respond d...ding to a study presented today at the annual meet...RSNA). ,, "Men may direct more attention to sen...ess them in terms of implications for required act...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit M 5623 1VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit M 5623 2VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit M 5623 3Improving schools for disabled students is NJIT researchers mission 59864 1Improving schools for disabled students is NJIT researchers mission 59864 2Improving schools for disabled students is NJIT researchers mission 59864 3GreenHouse and Allard Research and Development Partner to Revolutionize Large Scale Ethanol Fuel Systems 14549 1GreenHouse and Allard Research and Development Partner to Revolutionize Large Scale Ethanol Fuel Systems 14549 2GreenHouse and Allard Research and Development Partner to Revolutionize Large Scale Ethanol Fuel Systems 14549 3
...O, May 20 A post hoc analysis showing,time to sym...hire plc,s,(LSE: SHP, Nasdaq: SHPGY) ulcerative co...ay at Digestive Disease Week (DDW). Study 302 (fur...l A. Kamm, from St Mark,s,Hospital in London, UK),...ission in patients with active, mild to moderate u...
... May 20 GlaxoSmithKline and Synta,Pharmaceuticals...hase II,clinical data for elesclomol (formerly STA...lopment for metastatic melanoma. A retrospective a...atients treated with elesclomol,and paclitaxel who...atistically significant improvement in progression...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW 6Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 2Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 3Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 4Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 5Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 6Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 7
... easily couple with standard surgical C-arms. Quic...ime consuming delays. Optical coupling can be perf...ng arm provides ultrasound imaging, too. ,Positi...ich comes equipped with three exchangeable mid-sec...
Self-Cath® Plus Soft Cath (soft catheter)
Self-Cath® Plus Straight Tip - Female
Self-Cath Closed System Tapered Tip Coude with Guide Stripe, single units
Medicine Products: